Every material Form 8-K FIREFLY NEUROSCIENCE, INC. has filed with the SEC since June 26, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Firefly Neuroscience's board terminated Chief Financial Officer Paul Krzywicki on September 8, 2026, effective September 24, 2026, and stated the decision was not the result of any disagreement over the company's operations, policies or practices. The company also appointed Jessica Paz as Chief Accounting Officer, with an annual base salary of $215,000 and a stock option for 50,000 shares. The filing does not name a successor CFO.
Board terminated CFO Paul Krzywicki on September 8, 2026, effective September 24, 2026
Termination was stated to be unrelated to any disagreement on operations, policies or practices
Jessica Paz employed as Chief Accounting Officer effective September 8, 2026, at $215,000 annual base salary
Paz received a stock option for 50,000 shares, vesting over four years with 25% after the first anniversary
At its August 5, 2026 annual meeting, Firefly Neuroscience stockholders approved reducing the company's authorized shares from 5,001,000,000 to 101,000,000, effective the same day. They also approved adding 2,000,000 shares to the 2024 Long-Term Incentive Plan and updating its evergreen provision, which affects potential future share issuance to employees and directors.
Authorized shares cut from 5,001,000,000 to 101,000,000 (100,000,000 common and 1,000,000 preferred), effective August 5, 2026
2024 Long-Term Incentive Plan share limit raised by 2,000,000 shares, with evergreen provision updated
Arun Menawat elected Class III director with 4,324,584 votes for and 106,395 withheld
Quorum of 9,703,536 of 15,604,571 shares outstanding as of the June 8, 2026 record date
Firefly Neuroscience and an accredited investor mutually agreed in writing on June 25, 2026 to terminate a securities purchase agreement dated May 6, 2026. The deal would have sold up to 666,667 units at $1.50 per unit, for up to $1,000,000 in gross proceeds. The filing does not give a reason for the termination, and the company does not say whether it will seek other financing.
Purchase agreement dated May 6, 2026 covered up to 666,667 units at $1.50 per unit
Aggregate gross proceeds of up to $1,000,000 were contemplated
Termination mutually agreed in writing on June 25, 2026, effective as of that date
Filing made under Item 1.02 and signed by CEO Greg Lipschitz on June 26, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every FIREFLY NEUROSCIENCE, INC. filing is on SEC EDGAR ↗. 8-K briefs of other companies →